2020
DOI: 10.1177/2045894020935289
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐synthetase syndrome‐associated pulmonary veno‐occlusive disease

Abstract: Pulmonary arterial hypertension has been reported with a prevalence of 7.9% in patients with anti-synthetase syndrome; however, anti-synthetase syndrome associated with pulmonary veno-occlusive disease (PVOD) has never before been described in the literature. We present a novel case of anti-synthetase syndrome-associated PVOD in a patient who presented with hypoxic respiratory failure associated with right heart failure and was diagnosed with anti-synthetase syndrome based on his autoimmune serology a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Among patients with ASS, ILD is the main clinical feature and prognostic factor with an incidence of up to 80%, while PAH secondary to ILD is also frequently reported[ 9 ]. Approximately 7.9% of patients with ASS develop PAH[ 19 ]. It has been shown that PAH is usually severe and is believed to be related to Raynaud’s phenomenon, which is commonly associated with ASS[ 19 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Among patients with ASS, ILD is the main clinical feature and prognostic factor with an incidence of up to 80%, while PAH secondary to ILD is also frequently reported[ 9 ]. Approximately 7.9% of patients with ASS develop PAH[ 19 ]. It has been shown that PAH is usually severe and is believed to be related to Raynaud’s phenomenon, which is commonly associated with ASS[ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 7.9% of patients with ASS develop PAH[ 19 ]. It has been shown that PAH is usually severe and is believed to be related to Raynaud’s phenomenon, which is commonly associated with ASS[ 19 ]. A case report and literature review by García-Fernández et al [ 9 ] explored the relationship between ASS and PAH, and revealed that while their patients had stable and mild ILD, PAH at follow-up was disproportionate and unrelated to ILD severity.…”
Section: Discussionmentioning
confidence: 99%
“…Zöller et al have described autoimmune diseases as hypercoagulable disorders, which is attributed to their inflammatory role in cytokine cascade-mediated upregulation of pro-coagulants, inhibition of the protein C system and inhibition of fibrinolysis and the development of autoantibodies [ 12 ]. Three cases of the extra-ocular vaso-occlusive disease in ASS have been reported in the literature: a case of vaso-occlusive digital ischaemia in a 61-year-old Caucasian lady with anti-PL7 antibodies [ 13 ]; a case of pulmonary vaso-occlusive disease in a 55-year-old male with anti-Jo-1 antibodies [ 14 ]; and a case of a concurrent stroke at the time of ASS diagnosis in a 52-year-old Southeast Asian lady with anti-Jo-1 antibodies [ 15 ]. Interestingly, the patient in the first case developed vaso-occlusive disease prior to ILD symptoms, similar to our case, indicating that vaso-occlusive disease may be a precursor to severe ILD in patients with anti-PL7 antibodies.…”
Section: Discussionmentioning
confidence: 99%